Cigna Group Stock Price, News & Analysis

Evernorth (NYSE:CI) unveiled a new rebate-free Express Scripts pharmacy benefit model on Oct 27, 2025 to lower drug costs, improve price transparency, and boost support for local pharmacies.

The plan promises an average 30% reduction in monthly brand-name prescription costs for people who pay full price, automatic selection of the lowest available price at the pharmacy counter, and clinical safeguards including thousands of safety checks. Cigna Healthcare will adopt the model for fully insured lives in 2027; it becomes standard for all Evernorth pharmacy clients in 2028. New pharmacy reimbursement takes effect across in-network pharmacies in 2026.

The Cigna Group (NYSE: CI) declared a quarterly cash dividend of $1.51 per share, payable on December 18, 2025 to shareholders of record as of the close of business on December 4, 2025.

The dividend applies to common stock and specifies the payment and record dates for investor planning.

The Cigna Group Foundation (NYSE: CI) released its Improving Youth Mental Health 2025 Impact Report on October 9, 2025, detailing its first-year youth mental health grant program across 10 states.

The Foundation distributed $3 million in grants to 23 nonprofit partners, reaching over 34,000 youth, families, and professionals through school programs, clinical services, and workshops. Reported activity totals include 8,576 youth education sessions and 4,392 therapy sessions; grantees reported outcome achievement rates up to 94%.

This work is part of a $27 million, three-year investment; a new application period opens in early 2026.

The Cigna Group (NYSE:CI) has scheduled its third quarter 2025 financial results release and conference call for Thursday, October 30, 2025. The financial results will be released by 6:30 a.m. ET, followed by a management conference call at 8:30 a.m. ET.

Participants are encouraged to join the call by 8:15 a.m. ET. The call replay will be available from 12:30 p.m. ET on October 30 until 10:59 p.m. ET on November 13, 2025. A live webcast will be accessible through the company's investor relations website, along with the news release and financial supplement.

The Cigna Group (NYSE:CI), a global health company, announced that its President and COO Brian Evanko and EVP and CFO Ann Dennison will present at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 10, 2025, in New York. The presentation is scheduled to begin at 8:30 a.m. ET.

Investors can access a live webcast of the presentation through The Cigna Group's investor relations website. Interested parties should visit the website at least 15 minutes before the presentation to download any necessary audio software.

AM Best has assigned a "bbb+" (Good) Long-Term Issue Credit Rating to The Cigna Group's (NYSE: CI) new senior unsecured notes totaling $4.5 billion. The debt issuance includes four tranches: $1B at 4.5% due 2030, $1.25B at 4.875% due 2032, $1.5B at 5.25% due 2036, and $750M at 6.0% due 2056.

The proceeds will be used to repay $2 billion of existing term loans and for general corporate purposes. While Cigna's adjusted financial leverage ratio of 43.3% is expected to temporarily increase, AM Best anticipates it will decrease to approximately 40% by 2026. The company maintains strong debt-servicing capabilities with over 6x interest coverage and excellent financial flexibility supported by a $6.5 billion revolving credit agreement.

Evernorth Health Services, a subsidiary of The Cigna Group (NYSE: CI), has announced a $3.5 billion investment in Shields Health Solutions, acquiring preferred stock in the specialty pharmacy management company. This investment coincides with Shields becoming a private standalone company following its acquisition by Sycamore Partners from Walgreens Boots Alliance.

Shields partners with over 80 health systems comprising more than 1,000 hospitals and clinics across nearly all 50 states, helping them develop and manage specialty pharmacies. The investment aligns with Evernorth's strategy to enhance its presence in the growing specialty medicine market while supporting patients with complex and chronic conditions.

The transaction is not expected to materially impact The Cigna Group's 2025 adjusted EPS guidance of at least $29.60. The deal provides Evernorth with options for additional future investment in Shields.

Cigna Healthcare (NYSE:CI) is expanding its flexible dental payment program in partnership with Paytient to 2.8 million additional members nationwide, extending access to mid-market employers with as few as 250 enrolled members.

The program has shown significant success, with 92.9% of members reporting they would have skipped care without the Paytient card. The solution received a strong Net Promoter Score of 83.4 and a 4.89 rating on Trustpilot. Notably, 44.7% of users came from communities with high or very high Social Determinants of Health risk, compared to 30.7% of their coworkers, demonstrating its impact on health equity.

The program allows members to access dental care when needed and pay over time, particularly beneficial for procedures exceeding the typical $1,500 annual dental benefit cap.

The Cigna Group (NYSE: CI) reported strong Q2 2025 financial results with total revenues increasing 11% to $67.2 billion. The company achieved shareholders' net income of $1.5 billion, or $5.71 per share, and adjusted income from operations of $1.9 billion, or $7.20 per share.

Evernorth Health Services showed significant growth with adjusted revenues up 17% and adjusted income from operations increasing 5%. The company maintained 182.2 million total customer relationships, with pharmacy customers growing 3% to 121.9 million. Cigna Healthcare's Medical Care Ratio was 83.2% in Q2 2025.

The company reaffirmed its 2025 outlook for adjusted income from operations of at least $29.60 per share, demonstrating confidence in its business performance and growth strategy.